Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2026-03-03 @ 2:35 PM
Study NCT ID:
NCT04656418
Status:
COMPLETED
Last Update Posted:
2023-06-29
First Post:
2020-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks
Sponsor:
CSL Behring
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-27
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-07
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-01
First Submit QC Date:
None
Study First Post Date:
2020-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-07
Results First Submit QC Date:
None
Results First Post Date:
2023-06-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-07
Last Update Post Date:
2023-06-29
Last Update Post Date Type:
ACTUAL